Oral Immunoglobulin for the Prevention of Rotavirus Infection in Low Birth Weight Infants

Overview

Journal Cochrane Database Syst Rev

Publisher Wiley

Specialties General Medicine
Health Services

Date 2011 Nov 11

PMID 22071808

Citations 3

Authors

Mohan Pammi

Khalid N Haque

Affiliations

Soon will be listed here.

Abstract

Background: Rotavirus is a common neonatal nosocomial viral infection and epidemics with the newer P(6)G9 strains have been reported. Local mucosal immunity in the intestine to rotavirus is important in the resolution of infection and protection against subsequent infections. Oral administration of anti-rotaviral immunoglobulin preparations might be a useful strategy in preventing rotaviral infections, especially in low birth weight babies.

Objectives: To determine the effectiveness and safety of oral immunoglobulin preparations for the prevention of rotavirus infection in hospitalized low birthweight infants (birthweight < 2500 g)

Search Methods: The Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library), MEDLINE, EMBASE, CINAHL, biological Abstracts (BIOSIS), Science Citation Index for articles citing Barnes 1982 and the proceedings of the Pediatric Academic Societies from 1991 onwards were searched in July 2011. Ongoing trials were also searched at clinicaltrials.gov and controlled-trials.com

Selection Criteria: The criteria used to select studies for inclusion were: 1) design: randomized or quasi-randomized controlled trials; 2) participants: hospitalized low birthweight infants; 3) intervention: oral immunoglobulin preparations for prevention of rotavirus infection compared to placebo OR no intervention; 4) at least one of the following outcomes were reported: all cause mortality during hospital stay, mortality due to rotavirus infection during hospital stay, rotavirus infection , duration of diarrhea, need for rehydration, duration of viral excretion, duration of infection control measures, length of hospital stay in days, recurrent diarrhea or chronic diarrhea.

Data Collection And Analysis: The two review authors independently abstracted data from the included trials.

Main Results: One published study (Barnes 1982) was eligible for inclusion in this review. Barnes 1982 found no significant difference in the rates of rotavirus infection after oral gammaglobulin versus placebo in hospitalized low birthweight babies [RR 1.27 (95% CI 0.65 to 2.37)]. In the subset of infants who became infected with rotavirus after receiving gammaglobulin or placebo for prevention of rotavirus infection, there was no significant difference in the duration of rotavirus excretion between the group who had gammaglobulin (mean 2 days, range 1 to 4 days) and the group who had placebo (mean 3 days, range 1 to 6 days). Barnes 1982 reported no adverse effects after administration of oral immunoglobulin preparations.

Authors' Conclusions: Current evidence does not support the use of oral immunoglobulin preparations to prevent rotavirus infection in low birthweight infants. Researchers are encouraged to conduct well-designed neonatal trials using the newer preparations of anti-rotaviral immunoglobulins (colostrum, egg yolk immunoglobulins) and include cost effectiveness evaluations.

Citing Articles

Mega-map of systematic reviews and evidence and gap maps on the interventions to improve child well-being in low- and middle-income countries.

Saran A, White H, Albright K, Adona J Campbell Syst Rev. 2023; 16(4):e1116.

PMID: 37018457 PMC: 8356294. DOI: 10.1002/cl2.1116.

Adverse Effects of Immunoglobulin Therapy.

Guo Y, Tian X, Wang X, Xiao Z Front Immunol. 2018; 9:1299.

PMID: 29951056 PMC: 6008653. DOI: 10.3389/fimmu.2018.01299.

Is There a Role for the Enteral Administration of Serum-Derived Immunoglobulins in Human Gastrointestinal Disease and Pediatric Critical Care Nutrition?.

Van Arsdall M, Haque I, Liu Y, Rhoads J Adv Nutr. 2016; 7(3):535-43.

PMID: 27184280 PMC: 4863275. DOI: 10.3945/an.115.011924.

References

Ward R . Mechanisms of protection against rotavirus in humans and mice. J Infect Dis. 1996; 174 Suppl 1:S51-8. DOI: 10.1093/infdis/174.supplement_1.s51. View

Sarker S, Casswall T, Juneja L, Hoq E, Hossain I, FUCHS G . Randomized, placebo-controlled, clinical trial of hyperimmunized chicken egg yolk immunoglobulin in children with rotavirus diarrhea. J Pediatr Gastroenterol Nutr. 2001; 32(1):19-25. DOI: 10.1097/00005176-200101000-00009. View

Valmari P, Pontynen S, Sunila R . Rotavirus infection in a neonatal unit. Ann Clin Res. 1984; 16(3):167-70. View

Cubitt W, Steele A, Iturriza M . Characterisation of rotaviruses from children treated at a London hospital during 1996: emergence of strains G9P2A[6] and G3P2A[6]. J Med Virol. 2000; 61(1):150-4. DOI: 10.1002/(sici)1096-9071(200005)61:1<150::aid-jmv24>3.0.co;2-w. View

Riedel F, Kroener T, Stein K, Nuesslein T, Rieger C . Rotavirus infection and bradycardia-apnoea-episodes in the neonate. Eur J Pediatr. 1996; 155(1):36-40. DOI: 10.1007/BF02115624. View

Sarker S, Casswall T, Mahalanabis D, Alam N, Albert M, Brussow H . Successful treatment of rotavirus diarrhea in children with immunoglobulin from immunized bovine colostrum. Pediatr Infect Dis J. 1999; 17(12):1149-54. DOI: 10.1097/00006454-199812000-00010. View

Sharma R, Garrison R, Tepas 3rd J, Mollitt D, Pieper P, Hudak M . Rotavirus-associated necrotizing enterocolitis: an insight into a potentially preventable disease?. J Pediatr Surg. 2004; 39(3):453-7. DOI: 10.1016/j.jpedsurg.2003.11.016. View

Blum P, Phelps D, Ank B, Krantman H, Stiehm E . Survival of oral human immune serum globulin in the gastrointestinal tract of low birth weight infants. Pediatr Res. 1981; 15(9):1256-60. DOI: 10.1203/00006450-198109000-00006. View

Tufvesson B, Polberger S, Svanberg L, Sveger T . A prospective study of rotavirus infections in neonatal and maternity wards. Acta Paediatr Scand. 1986; 75(2):211-5. DOI: 10.1111/j.1651-2227.1986.tb10186.x. View

10.

Parashar U, Hummelman E, Bresee J, Miller M, Glass R . Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 2003; 9(5):565-72. PMC: 2972763. DOI: 10.3201/eid0905.020562. View

11.

Kilgore P, Unicomb L, Gentsch J, Albert M, McElroy C, Glass R . Neonatal rotavirus infection in Bangladesh: strain characterization and risk factors for nosocomial infection. Pediatr Infect Dis J. 1996; 15(8):672-7. DOI: 10.1097/00006454-199608000-00007. View

12.

Ebina T . Prophylaxis of rotavirus gastroenteritis using immunoglobulin. Arch Virol Suppl. 1996; 12:217-23. DOI: 10.1007/978-3-7091-6553-9_23. View

13.

Turner R, Kelsey D . Passive immunization for prevention of rotavirus illness in healthy infants. Pediatr Infect Dis J. 1993; 12(9):718-22. DOI: 10.1097/00006454-199309000-00003. View

14.

Mogilner B, Miskin A, Shif I, Aboudi Y . Necrotizing enterocolitis associated with rotavirus infection. Isr J Med Sci. 1983; 19(10):894-6. View

15.

Jayashree S, Bhan M, Kumar R, Bhandari N, Sazawal S . Protection against neonatal rotavirus infection by breast milk antibodies and trypsin inhibitors. J Med Virol. 1988; 26(3):333-8. DOI: 10.1002/jmv.1890260313. View

16.

Chrystie I, Totterdell B, Banatvala J . Asymptomatic endemic rotavirus infections in the newborn. Lancet. 1978; 1(8075):1176-8. PMC: 7173156. DOI: 10.1016/s0140-6736(78)90967-4. View

17.

Widdowson M, van Doornum G, van der Poel W, de Boer A, van de Heide R, Mahdi U . An outbreak of diarrhea in a neonatal medium care unit caused by a novel strain of rotavirus: investigation using both epidemiologic and microbiological methods. Infect Control Hosp Epidemiol. 2002; 23(11):665-70. DOI: 10.1086/501991. View

18.

. Prevention of rotavirus disease: updated guidelines for use of rotavirus vaccine. Pediatrics. 2009; 123(5):1412-20. DOI: 10.1542/peds.2009-0466. View

19.

Bryden A, Thouless M, Hall C, Flewett T, Wharton B, Mathew P . Rotavirus infections in a special-care baby unit. J Infect. 1982; 4(1):43-8. DOI: 10.1016/s0163-4453(82)90988-4. View

20.

Mohan P, Haque K . Oral immunoglobulin for the prevention of rotavirus infection in low birth weight infants. Cochrane Database Syst Rev. 2003; (3):CD003740. DOI: 10.1002/14651858.CD003740. View